Life Sciences In Action Podcast: Interview with Brad Brown, CEO of ATL Technologies on Tariffs, Manufacturing Overseas, Quality and More
January 17, 2019
The recent tariffs placed on imports have complicated the manufacturing and distribution processes for any life sciences company doing business overseas. In the pilot episode of the Life Scienes in Action Podcast Series, BioUtah president and CEO, Kelvyn Cullimore, interviews Brad Brown, CEO and chairman of ATL Technology, to discuss how the tarriffs have impacted their business. Other topics discussed include:
- Factors influencing overseas manufacturing
- The importance of quality in the manufacturing process
- Vertical integration of the manufacturing process
- What to look for when selecting a medical device manufacturer
- The importance of life sciences companies participating in BioUtah
Recent News
- Nucleus Institute Convergence Point Groundbreaking
- EDWARDS LIFESCIENCES RECEIVES FDA APPROVAL FOR AUTUS VALVE
- Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
- Owlet Announces Creation of Baby Safety Task Force to Educate, Innovate, and Advocate for Better Baby Safety Standards
- BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
- Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization
